Injectable Drug Delivery Technologies Market

Report Description
Table of Contents

Report Description

The global injectable drug delivery technologies market size is estimated to be USD 595.8 billion in 2021 and is expected to witness a CAGR of 12.45% during the forecast period. Acceleration in the global demand for self- injection devices is a key driver for the growth of the global injectable drug delivery technologies market. Additionally, the surge in the number of patients suffering from chronic diseases and high rate of technological innovation in the market in the injectable drug delivery technologies market are some of the other drivers propelling the market growth. Nevertheless, the rising incidence of needle stick injuries and preference for alternative modes of drug delivery is expected to restrain the global market growth.

Global Injectable Drug Delivery Technologies Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Drug Delivery

Based on drug delivery, the market is segmented into formulations and devices. In 2021, the formulations segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increasing investment R&D and the usage of colloidal dispersions in the drug delivery systems is significantly rising worldwide. Devices segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing use of these devices as they help in the management and control of several disorders at the initial level.

By Therapeutic Use

Based on therapeutic use, the market is categorized into hormonal disorders, autoimmune disorders, oncology, and others. In 2021, the oncology segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the use of chemotherapy for the treatment of cancer use injectable drug delivery devices to a great range worldwide. The hormonal disorders segment is anticipated to grow at a profitable CAGR during the forecast period, due to the launch of new products and shift towards the treatment of growth hormone deficiency are the key factors driving the market worldwide.

By End User

Based on end user, the market is categorized into homecare settings, hospital, and others. In 2021, the homecare settings segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the increase in the number of patients who are able to administer drugs at home without any medical help worldwide. The hospital segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increasing number of diabetic patients globally.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the favorable repayment scenarios, presence of major players in the region, accessibility of technologically advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the less stringent regulations, growing government and corporate investment in the healthcare sector, large population in various countries in the region, and availability of skilled labour forces at economic costs, are the major factors in this region.

Competitor Insights

Some of the key players in the injectable drug delivery technologies market are Pfizer, Inc. (U.S.); Baxter International, Inc. (U.S.); Schott AG (Germany); Becton, Dickinson and Company (U.S.); Eli Lilly and Company (U.S.); Alkermes PLC (Ireland); Terumo Corporation (Japan); Elcam Medical (Israel); Unilife Corporation (U.S.); and Ypsomed (Switzerland). The leading players operating in the injectable drug delivery technologies industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The injectable drug delivery technologies market report is categorized into the following segments and subsegments: